Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19-2 | COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) | PFIZER\BIONTECH | 1 | na4452 | IM / LA |
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Fever-Mild, Systemic: SLEPT TILL 1 PM THE NEXT DAY-Medium, Systemic: Headache-Mild, Additional Details: SHE HAD REDNESS IN HER ARM, AND SHE WENT TO URGENT CARE ON THE 29TH AND WAS TODL SHE HAS CELLULITIS. SHE WAS GIVEN BACRIM DS AND IT HAS GOTTEN BETTER, Other Vaccines: VaccineTypeBrand: Flu; Manufacturer: glaxosmithkline; LotNumber: 5R4CY; Route: IM; BodySite: LEFT DELTOID; Dose: ; VaxDate: UNKNOWN
NKDA